There are 2789 resources available
151P - The impact of limb hypothermia on the incidence and severity of paclitaxel induced peripheral neuropathy in breast cancer patients
Presenter: Alzahraa Azab
Session: ePoster Display
152P - Meta-analysis of the prognostic value of circulating tumor DNA (ctDNA) in patients (pts) with early breast cancer (EBC)
Presenter: Nadia Saoudi Gonzalez
Session: ePoster Display
153P - Adjuvant endocrine therapy combined with abemaciclib in monarchE patients with high-risk early breast cancer: Disease characteristics and endocrine therapy choice by menopausal status
Presenter: Shani Paluch-Shimon
Session: ePoster Display
154P - Five-year follow-up of the phase III study comparing SB3 (trastuzumab biosimilar) and reference trastuzumab in patients with HER2 positive early or locally advanced breast cancer
Presenter: Xavier Pivot
Session: ePoster Display
205P - Immunomodulation in early triple-negative breast cancer (TNBC): Analysis of soluble markers as predictive biomarkers to neoadjuvant chemotherapy in TNBC
Presenter: Martin Nunez Abad
Session: ePoster Display
206P - Disease behavior and treatment response of special histological types of triple-negative breast cancer
Presenter: Renata Bonadio
Session: ePoster Display
207P - Outcomes of patients with triple-negative breast cancer following neoadjuvant chemotherapy with anthracycline and taxane-based regimens plus carboplatin
Presenter: Bryan Vaca Cartagena
Session: ePoster Display
208P - ARB: Phase II window of opportunity study of preoperative treatment with enzalutamide in ER+ve and TNBC
Presenter: Peter Schmid
Session: ePoster Display
209P - Interim results of a phase I/Ib study of SBT6050 monotherapy and pembrolizumab combination in patients with advanced HER2-expressing or amplified solid tumors
Presenter: Samuel Klempner
Session: ePoster Display